{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:12:37Z","timestamp":1792613557914,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR135366"],"award-info":[{"award-number":["NIHR135366"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X004724\/1"],"award-info":[{"award-number":["MR\/X004724\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.lanmic.2026.101360","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:10:34Z","timestamp":1776985834000},"page":"101360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nirmatrelvir\u2013ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022\u201323: virological and immunological results of an open-label randomised trial (PANORAMIC)"],"prefix":"10.1016","volume":"7","author":[{"given":"David M","family":"Lowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7404-7800","authenticated-orcid":false,"given":"Laura","family":"Buggiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-2156","authenticated-orcid":false,"given":"Adrian M","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8704-8940","authenticated-orcid":false,"given":"Elen","family":"Ashmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ly-Mee","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2769-0967","authenticated-orcid":false,"given":"Saye","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F D Richard","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F","family":"Standing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Cureton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A","family":"Detry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jienchi","family":"Dorward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Ee","family":"Png","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oghenekome A","family":"Gbinigie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel D","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhautesh D","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerenza","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Marion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Mort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S","family":"Nguyen-Van-Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra G","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Petrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib M","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan B","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina T","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Carson-Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P B","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ustianowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"van Hecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"and","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Ashford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadua","family":"Bayzid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Dinally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Hatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Thalasselis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Uwenedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Yongblah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2026.101360_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2026.101360_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2026.101360_bib4","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJMoa2309003","article-title":"Nirmatrelvir for vaccinated or unvaccinated adult outpatients with COVID-19","volume":"390","author":"Hammond","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2026.101360_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(22)02597-1","article-title":"Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial","volume":"401","author":"Butler","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2026.101360_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105970","article-title":"Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants","volume":"230","author":"Rosales","year":"2024","journal-title":"Antiviral Res"},{"key":"10.1016\/j.lanmic.2026.101360_bib7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/14787210.2024.2339398","article-title":"The effectiveness of novel oral antiviral treatment for non-hospitalised high-risk patients with COVID-19 during predominance of omicron XBB subvariants","volume":"22","author":"Hsu","year":"2024","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.lanmic.2026.101360_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/M22-3565","article-title":"Effectiveness of COVID-19 treatment with nirmatrelvir\u2013ritonavir or molnupiravir among US veterans: target trial emulation studies with one-month and six-month outcomes","volume":"176","author":"Bajema","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lanmic.2026.101360_bib9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(22)01586-0","volume":"400","author":"Wong","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2026.101360_bib10","article-title":"Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the omicron era in Italy: a nationwide, cohort study","volume":"31","author":"Torti","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanmic.2026.101360_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-069176","volume":"13","author":"Gbinigie","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.lanmic.2026.101360_bib12","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41467-024-45641-0","article-title":"Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients","volume":"15","author":"Standing","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanmic.2026.101360_bib13","unstructured":"Butler CC, Pinto AD, Harris V, et al., Oral nirmatrelvir\u2013ritonavir for COVID-19 in higher risk outpatients, NEJM, (in press)."},{"key":"10.1016\/j.lanmic.2026.101360_bib14","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cpt.2646","article-title":"Recommendations for the management of drug\u2013drug interactions between the COVID-19 antiviral nirmatrelvir\/ritonavir (Paxlovid) and comedications","volume":"112","author":"Marzolini","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lanmic.2026.101360_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(23)00493-0","article-title":"Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial","volume":"24","author":"Schilling","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101360_bib16","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s40121-024-00994-3","article-title":"Clinical outcome and 7-day virological clearance in high-risk patients with mild-moderate COVID-19 treated with molnupiravir, nirmatrelvir\/ritonavir, or remdesivir","volume":"13","author":"Bai","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.lanmic.2026.101360_bib17","article-title":"Comparative effectiveness of nirmatrelvir\/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during omicron waves: observational cohort study using the OpenSAFELY platform","volume":"34","author":"Zheng","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanmic.2026.101360_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102225","article-title":"Effectiveness of molnupiravir vs nirmatrelvir\u2013ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study","volume":"64","author":"Wan","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.lanmic.2026.101360_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298254","article-title":"Nirmatrelvir\/ritonavir or molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression","volume":"19","author":"Butt","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2026.101360_bib20","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/vaccines10101731","article-title":"Nirmatrelvir\/ritonavir and molnupiravir in the treatment of mild\/moderate COVID-19: results of a real-life study","volume":"10","author":"Gentile","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lanmic.2026.101360_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01829-24","article-title":"The effect of molnupiravir and nirmatrelvir on SARS-CoV-2 genome diversity in severe models of COVID-19","volume":"13","author":"Penrice-Randal","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.lanmic.2026.101360_bib22","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1038\/s41467-024-49458-9","article-title":"A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy","volume":"15","author":"Esmaeili","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanmic.2026.101360_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/cid\/ciad102","article-title":"The coronavirus disease 2019 rebound study: a prospective cohort study to evaluate viral and symptom rebound differences in participants treated with nirmatrelvir plus ritonavir versus untreated controls","volume":"77","author":"Pandit","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101360_bib24","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJMc2205944","article-title":"Nirmatrelvir\u2013ritonavir and viral load rebound in COVID-19","volume":"387","author":"Anderson","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2026.101360_bib25","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.7326\/M23-1756","article-title":"SARS-CoV-2 virologic rebound with nirmatrelvir\u2013ritonavir therapy: an observational study","volume":"176","author":"Edelstein","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lanmic.2026.101360_bib26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/v16060864","article-title":"Antiviral use in mild-to-moderate SARS-CoV-2 infections during the omicron wave in geriatric patients","volume":"16","author":"Exquis","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.lanmic.2026.101360_bib27","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3390\/cells11060922","article-title":"Biomarkers associated with cardiovascular disease in COVID-19","volume":"11","author":"Kaufmann","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.lanmic.2026.101360_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-021-00839-5","article-title":"CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes","volume":"13","author":"Baker","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.lanmic.2026.101360_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13059-018-1618-7","article-title":"An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar","volume":"20","author":"Grubaugh","year":"2019","journal-title":"Genome Biol"},{"key":"10.1016\/j.lanmic.2026.101360_bib30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.lanmic.2026.101360_bib31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/molbev\/msu300","article-title":"IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies","volume":"32","author":"Nguyen","year":"2015","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.lanmic.2026.101360_bib32","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.3201\/eid2612.203309","article-title":"Sensitive detection of SARS-CoV-2-specific antibodies in dried blood spot samples","volume":"26","author":"Morley","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101360_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/cpt.2223","article-title":"Systematic review and patient-level meta-analysis of SARS-CoV-2 viral dynamics to model response to antiviral therapies","volume":"110","author":"Gastine","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lanmic.2026.101360_bib34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/2041-210X.13434","article-title":"Robustness of linear mixed-effects models to violations of distributional assumptions","volume":"11","author":"Schielzeth","year":"2020","journal-title":"Methods Ecol Evol"},{"key":"10.1016\/j.lanmic.2026.101360_bib35","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jclinepi.2013.03.017","article-title":"Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis","volume":"66","author":"Twisk","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.lanmic.2026.101360_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28430","article-title":"Coronavirus disease 2019 rebounds following nirmatrelvir\/ritonavir treatment","volume":"95","author":"Lai","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.lanmic.2026.101360_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl4013","article-title":"In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance","volume":"10","author":"Zhu","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.lanmic.2026.101360_bib38","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1021\/acs.biochem.2c00489","article-title":"Predicting antiviral resistance mutations in SARS-CoV-2 main protease with computational and experimental screening","volume":"61","author":"Sasi","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.lanmic.2026.101360_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.omtn.2023.03.013","article-title":"Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 omicron: another concern?","volume":"32","author":"Chatterjee","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.lanmic.2026.101360_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn8897","article-title":"Structural basis for potent antibody neutralisation of SARS-CoV-2 variants including B.1.1.529","volume":"376","author":"Zhou","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.lanmic.2026.101360_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae283","article-title":"Telemedicine for prescribing nirmatrelvir\/ritonavir: safety, logistics, and challenges","volume":"11","author":"Liebenstein","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101360_bib43","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S1473-3099(24)00183-X","article-title":"Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)","volume":"24","author":"Wongnak","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101360_bib44","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/j.jinf.2023.01.015","article-title":"Comparison of the clinical and virological characteristics of SARS-CoV-2 omicron BA.1\/BA.2 and omicron BA.5 variants: a prospective cohort study","volume":"86","author":"Kang","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.lanmic.2026.101360_bib45","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1016\/S2666-5247(23)00146-5","article-title":"Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study","volume":"4","author":"Lin","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2026.101360_bib46","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.15585\/mmwr.mm7251a1","article-title":"SARS-CoV-2 rebound with and without use of COVID-19 oral antivirals","volume":"72","author":"Smith","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.lanmic.2026.101360_bib47","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.15585\/mmwr.mm7251a2","article-title":"Evaluation of SARS-CoV-2 RNA rebound after nirmatrelvir\/ritonavir treatment in randomized, double-blind, placebo-controlled trials\u2014United States and International Sites, 2021\u20132022","volume":"72","author":"Harrington","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.lanmic.2026.101360_bib48","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10875-023-01504-9","article-title":"Persistent SARS-CoV-2 PCR positivity despite anti-viral treatment in immunodeficient patients","volume":"43","author":"Chan","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.lanmic.2026.101360_bib49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4062\/biomolther.2023.195","article-title":"Analysis of SARS-CoV-2 Mutations after nirmatrelvir treatment in a lung cancer xenograft mouse model","volume":"32","author":"Kang","year":"2024","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.lanmic.2026.101360_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn0396","article-title":"Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection","volume":"16","author":"Petro","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lanmic.2026.101360_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108959","article-title":"Effect of monoclonal antibody therapy on the endogenous SARS-CoV-2 antibody response","volume":"236","author":"Kim","year":"2022","journal-title":"Clin Immunol"},{"key":"10.1016\/j.lanmic.2026.101360_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(24)00431-6","article-title":"Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial","volume":"25","author":"Harris","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101360_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2022.114607","article-title":"Evaluation of the impact of pre-analytical conditions on sample stability for the detection of SARS-CoV-2 RNA","volume":"309","author":"Mosscrop","year":"2022","journal-title":"J Virol Methods"},{"key":"10.1016\/j.lanmic.2026.101360_bib54","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/dkac433","article-title":"Successful use of nirmatrelvir\/ritonavir in immunocompromised patients with persistent and\/or relapsing COVID-19","volume":"78","author":"Graziani","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lanmic.2026.101360_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad306","article-title":"Successful treatment of persistent symptomatic coronavirus disease 19 infection with extended-duration nirmatrelvir\u2013ritonavir among outpatients with hematologic cancer","volume":"10","author":"Liu","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101360_bib56","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S1473-3099(25)00221-X","article-title":"Extended nirmatrelvir\u2013ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial","volume":"25","author":"Weinstein","year":"2025","journal-title":"Lancet Infect Dis"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524726000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524726000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:37:04Z","timestamp":1783129024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524726000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666524726000157"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101360","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nirmatrelvir\u2013ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022\u201323: virological and immunological results of an open-label randomised trial (PANORAMIC)","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101360"}}